Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

307

Participants

Timeline

Start Date

December 22, 2016

Primary Completion Date

November 22, 2018

Study Completion Date

November 1, 2023

Conditions
Plasma Cell Myeloma
Interventions
DRUG

Isatuximab

Pharmaceutical form: solution for infusion Route of administration: intravenous

DRUG

Pomalidomide

Pharmaceutical form: capsule Route of administration: oral

DRUG

Dexamethasone

Pharmaceutical form: tablets or solution for infusion Route of administration: oral or intravenous

Trial Locations (111)

100

Investigational Site Number : 1580001, Taipei

333

Investigational Site Number : 1580003, Taoyuan District

833

Investigational Site Number : 1580004, Kaohsiung City

1070

Investigational Site Number : 6200002, Lisbon

1083

Investigational Site Number : 3480001, Budapest

1090

Investigational Site Number : 0560002, Brussels

1097

Investigational Site Number : 3480003, Budapest

1309

Investigational Site Number : 5540001, Takapuna

2025

Investigational Site Number : 5540002, Auckland

2060

Investigational Site Number : 0560003, Antwerp

2065

Investigational Site Number : 0360004, St Leonards

2298

Investigational Site Number : 0360001, Waratah

3000

Investigational Site Number : 0360005, Melbourne

Investigational Site Number : 0560001, Leuven

3004

Investigational Site Number : 0360002, Melbourne

3121

Investigational Site Number : 0360006, Richmond

3204

Investigational Site Number : 5540003, Hamilton

4032

Investigational Site Number : 3480002, Debrecen

4200

Investigational Site Number : 6200001, Porto

9000

Investigational Site Number : 0560004, Ghent

9016

Investigational Site Number : 5540004, Dunedin

9100

Investigational Site Number : 2080002, Aalborg

10126

Investigational Site Number : 3800003, Torino

11527

Investigational Site Number : 3000005, Athens

11528

Investigational Site Number : 3000001, Athens

12808

Investigational Site Number : 2030003, Prague

14033

Investigational Site Number : 2500008, Caen

15706

Investigational Site Number : 7240005, Santiago de Compostela

16132

Investigational Site Number : 3800008, Genova

20132

Investigational Site Number : 3800007, Milan

20133

Investigational Site Number : 3800002, Milan

21000

Investigational Site Number : 2500009, Dijon

21565

Investigational Site Number : 4100006, Incheon

26504

Investigational Site Number : 3000004, Pátrai

28006

Investigational Site Number : 7240003, Madrid

31008

Investigational Site Number : 7240002, Pamplona

31059

Investigational Site Number : 2500001, Toulouse

33324

BRCR Medical Center Inc. Site Number : 8400002, Plantation

33600

Investigational Site Number : 2500005, Pessac

34010

Investigational Site Number : 7920005, Istanbul

34295

Investigational Site Number : 2500019, Montpellier

34381

Investigational Site Number : 7920006, Istanbul

34390

Investigational Site Number : 7920003, Istanbul

35033

Investigational Site Number : 2500014, Rennes

35040

Investigational Site Number : 7920008, Izmir

35128

Investigational Site Number : 3800006, Padua

35340

Investigational Site Number : 7920010, Izmir

37007

Investigational Site Number : 7240004, Salamanca

37044

Investigational Site Number : 2500012, Tours

38039

Investigational Site Number : 7920009, Kayseri

38043

Investigational Site Number : 2500017, Grenoble

39008

Investigational Site Number : 7240006, Santander

40138

Investigational Site Number : 3800001, Bologna

40447

Investigational Site Number : 1580002, Taichung

41400

Investigational Site Number : 7920007, Kocaeli

44093

Investigational Site Number : 2500002, Nantes

50005

Investigational Site Number : 2030004, Hradec Králové

50134

Investigational Site Number : 3800009, Florence

51092

Investigational Site Number : 2500025, Reims

54511

Investigational Site Number : 2500018, Vandœuvre-lès-Nancy

57010

Investigational Site Number : 3000003, Thessaloniki

58128

Investigational Site Number : 4100007, Hwasun-gun

59037

Investigational Site Number : 2500003, Lille

62500

Investigational Site Number : 2030005, Brno

64100

Investigational Site Number : 2500021, Bayonne

69495

Investigational Site Number : 2500004, Pierre-Bénite

70852

Investigational Site Number : 2030002, Ostrava - Poruba

75005

Investigational Site Number : 2500015, Paris

75743

Investigational Site Number : 2500016, Paris

77900

Investigational Site Number : 2030001, Olomouc

83310

Investigational Site Number : 7030001, Bratislava

85925

Investigational Site Number : 2500013, La Roche-sur-Yon

86021

Investigational Site Number : 2500007, Poitiers

87042

Investigational Site Number : 2500023, Limoges

95123

Investigational Site Number : 3800010, Catania

97180

Investigational Site Number : 7520004, Luleå

125167

Investigational Site Number : 6430004, Moscow

125284

Investigational Site Number : 6430001, Moscow

129301

Investigational Site Number : 6430002, Moscow

02215

Dana Farber Site Number : 8400006, Boston

H1T 2M4

Investigational Site Number : 1240001, Montreal

H4A 3J1

Investigational Site Number : 1240004, Montreal

J1H 5N4

Investigational Site Number : 1240005, Sherbrooke

04103

Investigational Site Number : 2760001, Leipzig

106 76

Investigational Site Number : 3000002, Athens

05100

Investigational Site Number : 3800004, Terni

467-8602

Investigational Site Number : 3920001, Nagoya

377-0280

Investigational Site Number : 3920005, Shibukawa-shi

060-8543

Investigational Site Number : 3920004, Sapporo

603-8151

Investigational Site Number : 3920006, Kyoto

392-8510

Investigational Site Number : 3920008, Suwa-shi

701-1192

Investigational Site Number : 3920003, Okayama

411-8777

Investigational Site Number : 3920007, Sunto-gun

150-8935

Investigational Site Number : 3920002, Shibuya-ku

0450

Investigational Site Number : 5780001, Oslo

31-501

Investigational Site Number : 6160005, Krakow

20-081

Investigational Site Number : 6160003, Lublin

02-776

Investigational Site Number : 6160001, Warsaw

41-500

Investigational Site Number : 6160002, Chorzów

3000-075

Investigational Site Number : 6200004, Coimbra

03080

Investigational Site Number : 4100001, Seoul

06351

Investigational Site Number : 4100002, Seoul

06591

Investigational Site Number : 4100005, Seoul

08035

Investigational Site Number : 7240001, Barcelona

451 80

Investigational Site Number : 7520005, Uddevalla

06620

Investigational Site Number : 7920001, Ankara

07050

Investigational Site Number : 7920002, Antalya

Unknown

Investigational Site Number : 7920004, Istanbul

EC1A 7BE

Investigational Site Number : 8260002, London

SE1 9RT

Investigational Site Number : 8260003, London

WC1E6AG

Investigational Site Number : 8260001, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY